AI Article Synopsis
- Tumor necrosis factor (TNF) inhibitors are medications used to treat various immune-related diseases.
- They have significantly improved treatment strategies for patients with inflammatory bowel disease (IBD).
- The introduction of TNF inhibitors has transformed how IBD is managed clinically.
Article Abstract
Tumor necrosis factor (TNF) inhibitors are part of the therapeutic arsenal for many immune-mediated diseases and, especially in inflammatory bowel disease (IBD), have led to a change in the management of this disease.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.17235/reed.2022.8460/2021 | DOI Listing |
Publication Analysis
Top Keywords
infliximab-induced hypoglycemia
4
hypoglycemia rare
4
rare relevant
4
relevant side
4
side tumor
4
tumor necrosis
4
necrosis factor
4
factor tnf
4
tnf inhibitors
4
inhibitors therapeutic
4
Similar Publications
Infliximab-induced hypoglycemia, a rare but relevant side effect.
Rev Esp Enferm Dig
June 2022
Aparato Digestivo, Hospital Universitario de Navarra.
Article Synopsis
- Tumor necrosis factor (TNF) inhibitors are medications used to treat various immune-related diseases.
- They have significantly improved treatment strategies for patients with inflammatory bowel disease (IBD).
- The introduction of TNF inhibitors has transformed how IBD is managed clinically.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!